Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Oslo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Bionor Pharma ASA

+ Add to Watchlist

BIONOR:NO

2.300 NOK 0.020 0.88%

As of 10:25:18 ET on 04/17/2015.

Snapshot for Bionor Pharma ASA (BIONOR)

Open: 2.270 Day's Range: 2.250 - 2.320 Volume: 203,321
Previous Close: 2.280 52wk Range: 1.910 - 3.440 1-Yr Rtn: +8.49%

Stock Chart for BIONOR

No chart data available.
  • BIONOR:NO 2.300
  • 1D
  • 1M
  • 1Y
2.280
Interactive BIONOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIONOR

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. OBX -
Earnings Per Share (NOK) (ttm) -0.2935
Est. EPS (NOK) (12/2015) -0.2600
Est. PEG Ratio -
Market Cap (M NOK) 571.15
Shares Outstanding (M) 248.33
30 Day Average Volume 509,409
Price/Book (mrq) 3.5599
Price/Sale (ttm) 296.0747
Dividend Indicated Gross Yield -%
Cash Dividend (NOK) 2.6785
Dividend Ex-Date 12/12/2003
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIONOR

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for BIONOR

Bionor Pharma ASA is a biotechnology company. The Company develops therapeutic peptide vaccines that stimulate cell-mediated immunity. Bionor Pharma targets diseases that include chronic infections such as HIV, Hepatitis C (HCV), Human Papilloma Virus (HPV) and Influenza.

David Horn SolomonPresident/CEOSoren KellerSenior VP/Interim CFO/COO
Kamilla RolstedSenior VP/Chief Strategy & Bus OfcrBarbara A RuskinSenior VP/Chief Patent Ofcr/Gen Cnsl
More Company Profile & Key Executives for BIONOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil